|
LRI Awards $4.5 Million to Spur Innovation in Lupus Research
Fifteen Scientists to Pursue Novel Ideas on Understanding and Stopping the Destruction of Lupus
Following a rigorous review of a record number of
applications—92 in all—the Lupus Research Institute
Novel Research Peer Review Committee has selected 15
scientists to receive 3-year, $300,000 grants. As in
years past, the selection was based on the novelty
and potential of the hypotheses presented and on the
promise of the investigators themselves.
The scientists awarded the grants, which were
announced at the LRI's
"Forum for Discovery" scientific conference, are
attempting to
answer today's most pressing questions about lupus.
"The 2006 awards are a great mix of new
investigators embarking on novel research and
established investigators taking new directions,"
said Mark Shlomchik, MD, PhD, professor of
laboratory medicine and immunobiology at Yale
University School of Medicine.
With these awards, the Lupus Research Institute's
investment in novel lupus research totals almost $20
million, providing funding for 73 studies at 43
academic medical institutions in 22 states since its
founding in 2000.
Read
the Full Article »
2006
Lupus Research Institute Novel Grant Recipients:
+ Harvey Cantor, MD, Dana-Farber Cancer
Institute
+ Robert Eisenberg, MD, University of
Pennsylvania School of Medicine
+ Keith Elkon, MD, University of Washington
+ Jan Erikson, PhD, The Wistar Institute,
Philadelphia
+ Lee Ann Garrett-Sinha, PhD, SUNY Buffalo
+ Eric Greidinger, MD, University of Miami
Miller School of Medicine
+ Thereza Imanishi-Kari, PhD, Tufts University
School of Medicine
+ Michele Kosiewicz, PhD, University of
Louisville Research Foundation
+ Chau-Ching Liu, MD, PhD, University of
Pittsburgh School of Medicine
+ Jochen Mattner, MD, University of Chicago
+ Chandra Mohan, MD, PhD, University of Texas
Southwestern Medical Center
+ Stephen Pelsue, PhD, University of Southern
Maine
+ Alessandra Pernis, MD, Columbia University
Medical Center
+ Christopher Roman, PhD, SUNY-Downstate
Medical Center
+ Jian Zhang, MD, University of Chicago
View
details on 2006 Grants »
NIH Director Outlines Vision for Future at Annual LRI Scientific Conference
Says Lupus Research Institute has "Focused on What is Key"
Elias A. Zerhouni, MD, Director, National Institutes
of Health (NIH), presented the keynote address at the
LRI's
sixth annual "Forum for Discovery" conference
dinner on October 19, 2006, at the Yale Club in New
York. Dr. Zerhouni oversees the nation's top
health laboratory responsible for guiding the
research agenda and outlook for the NIH's vast
enterprise of 27 Institutes and Centers.
"I'm so pleased to hear about the Institute
and what you've accomplished in a very short time,"
Dr. Zerhouni said. "And what is really fascinating
to me is how you've really been able to focus on
what is key."
Read
more from Dr. Zerhouni's keynote address
»
Cautious Optimism on New Drugs for Lupus
Special LRI Scientific Conference Session Features Perspectives from Biotech, Pharma, and Academia
With the recent surge in knowledge about what causes
and promotes lupus generated by LRI researchers and
others, there appear to be—for the fist time
ever—several candidate drug "targets" for lupus with
enough potential to prompt biotechnology and
pharmaceutical companies to take a closer a look.
"I think in lupus the most exciting thing is that we
are now seeing the possibility of validated
targets," said Arthur Krieg, MD, a rheumatologist
who started a biotech company. Having targets is
crucial because they give drug developers something
to aim for with the goal of preventing, slowing, or
halting the disease. The targets are the first step
to safer and more
effective medicines—and a cure. Read
more about promising progress in lupus drug
development »
LUPUS
DRUG DEVELOPMENT »
Visit
www.LupusResearchInstitute.org for the latest on
lupus drug research and clinical trials results.
Researchers Report Significant Progress in Identification of Lupus Biomarkers at American College of Rheumatology Meeting
Lupus Research Institute-Funded Scientists Advance Key Biomarker Initiative
Six LRI-funded scientists reported findings on
biomarkers for lupus at the 2006 Annual Scientific
Meeting of the American College of Rheumatology
(ACR) in Washington, D.C. The eight reports
represent significant progress in the LRI's
biomarker research initiative, whic was launched in
2002 to increase the identification and validation
of these
early markers so critical for assessing
disease activity and organ damage in lupus and
determining response to therapy. Read
more about their findings »
Racial Disparities in Lupus Addressed at Congressional Briefing for First Time
Event Presented by the LRI National Coalition and Congresswoman Hilda L. Solis (D-CA)
Congressional staff, lupus advocates, and government
representatives gathered on Capitol Hill on October
4th for a briefing to hear about a long-neglected
subject: the devastating impact of the autoimmune
disease lupus on women of color. Read
more about this event »
A Time To Give
This Holiday Season, Give the Gift of Hope for a Cure
The holiday season is traditionally a time when we
express thanks for the blessings we have received,
and a time to pause and make plans for the future.
For many, it is also a time for sharing with
others through charitable gifts.
We hope that you will consider a year-end gift to
the Lupus Research Institute. A timely gift can
advance novel lupus research at the same time that
it reduces your 2006 income taxes. For
gift ideas and ways to give, visit our Donations
page »
To support lupus research each time you use the web,
log on to www.GoodSearch.org
and enter "Lupus Research Institute" as your charity
of choice. Every time
you use this search engine, you'll be helping to raise
funds for the fight against lupus.
Download the Discovery Update Newsletter
The latest issue of the LRI's official newsletter,
Discovery Update, is available now
online. Download
your copy here »
|
|
